Rigel Pharmaceuticals (RIGL) Retained Earnings (2010 - 2026)
Rigel Pharmaceuticals' (RIGL) quarterly Retained Earnings came in at -$128000.0 in Q1 2026, down 6300.0% year-on-year from $2064.5 in Q1 2025, and up 99.99% quarter-over-quarter from -$1.0 billion in Q4 2025.
Rigel Pharmaceuticals (RIGL) Retained Earnings (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Retained Earnings history runs 17 years deep, the most recent figure standing at -$128000.0 for Q1 2026.
- On a quarterly basis, Retained Earnings fell 6300.0% year-over-year to -$128000.0 in Q1 2026; TTM through Mar 2026 was -$128000.0, a 6300.0% decrease from a year earlier, with the FY2025 full-year figure at -$1.0 billion, down 10230510.0% from the prior year.
- Retained Earnings advanced to -$128000.0 in Q1 2026 per RIGL's latest filing, from -$1.0 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $10000.0 in Q4 2024 and bottomed at -$1.4 billion in Q2 2024.
- The 5-year median for Retained Earnings is -$1.0 billion (2025), against an average of -$709.0 million.
- Across the five-year window, Retained Earnings tumbled 17298350.0% in 2022 and soared 105.23% in 2023, its largest moves.
- Year by year, Retained Earnings stood at -$153000.0 in 2022, then soared by 105.23% to $8000.0 in 2023, then grew by 25.0% to $10000.0 in 2024, then sank by 10230510.0% to -$1.0 billion in 2025, then soared by 99.99% to -$128000.0 in 2026.
- Per Business Quant, the three latest RIGL Retained Earnings figures stand at -$128000.0 (Q1 2026), -$1.0 billion (Q4 2025), and -$1.3 billion (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn | -128,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128,000.00 |
| Dec 31, 2025 | -1.02 Bn |
| Sep 30, 2025 | -1.29 Bn |
| Jun 30, 2025 | -1.32 Bn |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | -1.40 Bn |
| Jun 30, 2024 | -1.42 Bn |
| Mar 31, 2024 | -1.42 Bn |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -1.40 Bn |
| Mar 31, 2023 | -1.40 Bn |
| Dec 31, 2022 | -153,000.00 |
| Sep 30, 2022 | -1.38 Bn |
| Jun 30, 2022 | -438,000.00 |
| Mar 31, 2022 | -416,000.00 |
| Dec 31, 2021 | -1.32 Bn |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | -1.28 Bn |